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According to a  current model for T  cell activation, stimulation of the T  cell 
receptor for antigen (TCR)' induces an increase in the density of cell surface IL- 
2-R  (1,  2),  as  well  as  the  secretion  of lymphokines,  including  IL-2.  Cellular 
proliferation occurs as  the  result of binding  of the secreted IL-2 to  the  newly 
induced receptors (3). This model seems to apply directly to Th, but not to most 
CTL.  Conventional  CTL do not  secrete  IL-2;  rather,  they require exogenous 
IL-2 in  addition  to alloantigen  for continued growth  in  culture (4).  In  mixed 
leukocyte cultures (MLC), Th secrete IL-2, which provides the signal for prolif- 
eration of both Th and IL-2-dependent CTL (5). 
However,  not  all  CTL  are  dependent  upon  IL-2  produced  by  Th.  Several 
investigators  have  described  cloned  CTL  that  can  proliferate  in  response  to 
appropriate antigenic challenge in  the absence of exogenous IL-2 (6-8).  Some 
of these Th-independent CTL secrete IL-2, and for these CTL, the IL-2-driven 
ntodel  for T  cell  proliferation  also  appears  to  be  applicable.  However,  other 
helper  cell-independent  CTL  do  not  secrete detectable  amounts  of IL-2  (8). 
The nature of the proliferative signal for these ceils has not been determined. 
Recently in our laboratory, we have been able to activate some of our cloned 
lines of CTL in the absence of exogenous IL-2 by using either specific antigen 
in  the  form  of T  cell-depleted  allogeneic  spleen  cells or  P-815  mastocytoma 
cells, or by using immobilized mAbs directed against the TCR. The stimulated, 
cloned CTL synthesize DNA and enter into cell cycle. They secrete macrophage 
activating  factor (MAF)  after  stimulation,  but  by  several  criteria  they  do  not 
synthesize IL-2. The proliferative response of these CTL after stimulation of the 
TCR  is  not  inhibited  by anti-IL-2-R  antibodies,  which  do block  IL-2-induced 
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TABLE  I 
mAbs Used in These Studies 
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mAb  Specificity  Reference 
384.5  Antigen Receptor on CTL L3  15 
KJ 16-133  Allotypic determinant on CTL dB45  20 
and Th L2 antigen receptor 
F23.1  Same as KJ16-133  21 
AT83A  Thy-1.2  22 
3.155  Lyt-2  23 
7D4  IL-2-R*  18 
3C7  1L-2-R*  16, 17 
PC61.5  IL-2-R*  19 
* mAb 3C7 and PC61.5  inhibit  IL-2 binding to IL-2-R; mAb 7D4 binds  to a 
separate  epitope of the IL-2-R and does not inhibit IL-2 binding. 
proliferation  of these cells. Our observations indicate that for conventional CTL 
there exists a  TCR-driven  pathway for proliferation  that is independent  of IL-2. 
Materials  and  Methods 
Animals.  C57BL/6, CBA, and DBA/2 mice, 6-8 wk of age were purchased from The 
Jackson Laboratory, Bar Harbor, ME. 
Cell Lines.  CTL clones L3 (4),  dB45, and BC9 (9) were used; these cloned cells are 
Thy-1 ÷, LFA-1 +, Lyt-2  +, and L3T4-. CTL clones L3, dB45, and BC9 are H-2Ld-reactive. 
Th clone L2 is Mls"'d-reactive and is Thy-1 +, LFA-1 +, Lyt-2-, and L3T4  ÷ (4). 
Cloned  T  lymphocytes were  maintained  routinely  by  weekly  passage  on  allogeneic 
•  •  137  •  spleen cells (irradiated with 2,000 rad from a  • Cesmm source) as a source of stimulating 
alloantigen,  together  with  conditioned  medium  containing  5-10  U/ml  of exogenous 
murine  IL-2, either  supernatants  from  secondary  mixed  lymphocyte cultures  (10),  or 
supernatants from PMA-stimulated EL-4 cells (EL-4 SF) (11). The cell lines were recloned 
at regular intervals by limiting dilution. Culture wells were harvested on the sixth, seventh, 
or eighth day of the culture cycle, and the cloned cells were isolated by Ficoll-Hypaque 
gradient  centrifugation  (12).  These  cells  were  washed  twice  and  suspended  in  culture 
medium. ([DME, H-21; Gibco Laboratories, Grand Island, NY] containing 5% FCS [KC 
Biological, Inc., Lenexa, KS],  10 mM 3-[N-morpholino]propanesulfonic acid, 5 X  10  -5 M 
2-ME,  100 U/ml penicillin,  100 #g/ml streptomycin, and additional amino acids [4,  13]). 
The IL-2-dependent cell line CTLL-20 (14) (generously provided by K. Smith,  Dart- 
mouth  Medical  School, Hanover,  NH) was used  in the  IL-2 assays. Several tumor lines 
were used in these studies• EL-4 is a T  cell lymphoma of C57BL/6 origin which produces 
IL-2 when stimulated  with  PMA (10 ng/ml) (Sigma Chemical Co., St.  Louis,  MO) (11). 
AKR-A is  a  T  cell  lymphoma  of AKR  (H-2  k)  origin.  P-815  mastocytoma cells  are  of 
DBA/2 origin and express K ~ and L d on the cell surface. P-815 cells do not express IL-2- 
R or secrete IL-2 (unpublished observations). 
Monoclonal Antibodies.  The  origin  and  characterization  of the  mAbs  used  in  these 
studies  are  listed  in  Table  I.  mAb 384.5  is a  clonotypic antibody that  reacts  with  the 
antigen  receptor  of CTL  clone  L3  (15).  Hybridomas  3C7  and  7D4  were  generously 
provided by T.  Malek at the  National  Institutes of Health,  Bethesda,  MD (16-18),  and 
hybridoma  PC61.5  was  generously  provided  by  M.  Nabholz  of the  Swiss  Institute  of 
Experimental  Cancer Research (19); the mAbs secreted by these hybridomas react with 
different epitopes  on the  I L-2-R.  Hybridoma KJ16-133  was generously provided by P. 
Marrack  at  the  National  Jewish  Hospital,  Denver,  CO  (20).  Hybridoma  F23.1  was 
generously provided  by  M.  Bevan  of the  Scripps  Clinic  and  Research  Foundation,  La 
Jolla,  CA (21).  mAb KJ16-133 and  mAb F23.1  appear to react with  the same allotypic 
determinant on the TCR. This determinant is expressed on CTL clone dB45 and on Th 1568  INTERLEUKIN  2-INDEPENDENT  PROLIFERATION  OF  T  CELLS 
clone L2. The two antibodies, mAb KJ16-133 and mAb F23.1, had the same functional 
effects  on  our  cell  lines and  were  used  interchangeably.  The  other  hybridomas were 
derived in this laboratory (22, 23). Hybridoma culture supernatants and ascites were used 
for  the  studies  in  this  paper,  mAb  PC61.5  and  mAb  7D4  were  partially purified  by 
ammonium sulfate precipitation, as previously described (24). 
Lymphokine Preparations.  Culture  medium  from  PMA-stimulated EL-4  cells was the 
usual source of murine  IL-2. Lymphokine-containing supernatants from  various cloned 
CTL and Th were obtained by culturing 107 cloned T  cells with either immobilized mAb 
384.5 or mAb F23.1  in 4 ml of cuhure medium for 3, 6, or 18 h. In other experiments, 
5  X  10 4 cloned CTL and Th were cultured with either 3.3  x  105  mitomycin C-treated 
P-815  cells,  106  DBA/2  splenocytes (irradiated 2,000  rad from  a  ~3VCesium source), or 
immobilized mAb  384.5  or  mAb  F23.1  for  various  periods of time  in  flat-bottomed 
microtiter wells (#3590;  Costar, Cambridge,  MA) in a  total volume of 0.2 ml. The cells 
were  then  removed  by centrifugation at  1500 g  for  5  min  and  the supernatants  were 
collected for assay of lymphokine titers. 
T  Cell Depletion.  T  cells were  selectively removed  from  spleen  cell populations  by 
treating with monoclonal anti-Thy-l.2 antibody (AT83A) and rabbit complement (25). 
Briefly,  108 spleen cells were incubated for 30  rain at 4°C  with  100  #1 AT83A culture 
supernatant in a final volume of 4  ml. The cells were washed once and resuspended in a 
1:3  dilution  of agar-adsorbed rabbit  serum  that  had  been  pretested  for  complement 
activity. After a  45  min incubation at 37°C,  cells were washed twice before addition to 
culture. Cell recoveries ranged from 50-70%. 
Mitomycin C Treatment of Tumor Cells.  Tumor cells were inactivated by treating them 
with mitomycin C  (Sigma Chemical Co.). Between  107-10 s P-815 or AKR-A tumor cells 
were centrifuged and resuspended in  1 ml Dulbecco's phosphate buffered saline solution 
(DPBS) containing 200 #g/ml mitomycin C. The cells were then incubated in the dark at 
37°C for I h, with occasional mixing. After the incubation, they were washed three times 
in culture medium containing 5% FCS before addition to cultures. 
Immobilization ofmAbs in Culture Wells.  To immobilize various mAbs to the surface of 
microtiter tray wells, mAb-containing solutions (50-100 #1) were added to microtiter wells 
(#3596, Costar) and incubated at 4°C for  18-24 h, or at 37°C for 2-3 h. The solutions 
were then aspirated, and the wells were washed two times with DPBS before the addition 
of cloned T  cells. Binding of the antibodies to the culture wells was monitored with an 
ELISA assay; all anti-TCR mAb used in these studies bound to microtiter wells (data not 
shown). 
Thymidine Incorporation Assay.  Thymidine incorporation by cloned T  cells was meas- 
ured by culturing various numbers of cloned T  cells with various stimuli in flat-bottomed 
nficrotiter wells (#3590 or #3596, Costar). 12 or 18 h before harvest, 1 #Ci [3H]thymidine 
(Amersham Corp., Arlington Heights, IL) in 0.025 ml culture medium was added to each 
well. Cultures were harvested onto glass fiber filter strips using an automated  PhD cell 
harvester (Cambridge Technology, Inc., Cambridge, MA) and samples were counted in a 
liquid scintillation spectrometer (Nuclear Chicago, Chicago, IL). Counts were corrected 
from counts per minute to disintegrations per minute (dpm) by the channels ratio method. 
Thymidine incorporation is presented as the mean _  SEM of triplicate cultures. 
DNA Content.  The relative DNA content of CTL L3 cells was measured by analyzing 
the binding of the fluorescent dye, propidium iodide (PI), to DNA in isolated CTL  L3 
cell nuclei (26). CTL L3 cells (106) were suspended in 0.25 ml DPBS, and 2 ml of staining 
solution (5  mg  PI,  100  mg sodium  citrate,  0.1  ml  Triton  X-100  in  100  ml  deionized 
water) were added. The cells were mixed with a vortex mixer for 15 s and incubated on 
ice for 15-30 rain. The resulting nuclei from the lysed CTL L3 cells were then centrifuged 
(1500 g  for  5  min), and resuspended in  1 ml  of cold Isoton II/PI (5  mg  PI in  100  ml 
Isoton II; Coulter Electronics Inc., Hialeah, FL). Histograms were recorded using a FACS 
analyzer (Becton Dickinson Immunocytometry Systems, Mountain View, CA). 
Assay  for IL-2.  IL-2 activity was determined by a  modification of the standard proce- 
dures (27)  by measuring relative amount  of uptake of 3-(4,5-alpha, methylthiazot-2-yl)- 
2,5-diphenyl tetrazolium bromide (MTT)  (Sigma Chemical Co.) by the  IL-2-dependent MOLDWIN  ET  AL.  1569 
cell line CTLL-20 in a  24-h assay (28).  We have determined that results obtained using 
this assay are comparable to results obtained by measuring thymidine incorporation  in 
CTLL-20 cells.  This assay consistently detected as little as 0.1  U/ml of IL-2. Units of IL- 
2 were calculated by comparison to a standard (No. ISDP-841) provided by the National 
Cancer Institute Biological Response Modifiers Program. 
Assay for  MAF.  MAF  activity  was  measured  by  determining  the  titer  of culture 
supernatant that induced 50% of maximal lysis of 51Cr-labeled  P-815 cells by C57BL/6- 
derived  bone  marrow  macrophages activated  with  lipopolysaccharide (Escherichia coli, 
0127:B8; Difco Laboratories Inc., Detroit, MI) (29). 
Identification of Lymphokine Messenger RNA (mRNA) in Cloned T Cells.  CTL L3, CTL 
dB45,  and Th  L2 cells at a concentration of 107 cells in  4  ml of culture  medium were 
stimulated with either immobilized mAb 384.5 or mAb F23.1 in 60 X 10-ram petri dishes 
(Falcon #1007,  Becton Dickinson & Co., Oxnard, CA). At the end of the culture period, 
the cells were detached from the petri dishes by adding 0.08 M EDTA in DME to a final 
concentration of 0.04 M. The cells were then harvested and washed in DPBS. 2.9 ml of 
4.0 M guanidine thiocyanate was added to 10  ~ cells, and the RNA was isolated using the 
cesium chloride  method,  with  a  second precipitation  of the  RNA  in  7.5  M  guanidine 
hydrochloride.  The  samples were washed,  dissolved in  water,  and  reprecipitated  with 
0.05  M potassium acetate in ethanol After rewashing, the amount of RNA present was 
quantified by measuring absorbance at 260 nm. 1.0 M glyoxal was added to equal amounts 
of RNA (~40 #g) with the modifications of procedures as described by Thomas (30).  The 
RNA samples were then either dotted directly onto Genescreen (New England Nuclear, 
Boston,  MA)  or  subjected  to  electrophoresis  in  a  1%  agarose  gel  and  transferred  to 
nitrocellulose (Schleicher  and  Schuell,  Inc.,  Keene,  NH).  The  Northern  and  dot  blots 
prepared in this manner were first hybridized to a 32p-labeled  cDNA probe for IL-2 (10 s 
cpm/¢g) and autoradiograms were made. The IL-2 probe was then removed and the blots 
were rehybridized to the cDNA probe for IFN-3' (kindly provided by Dr. Ken-ichi Arai, 
DNAX  Research Institute of Molecular and Cellular Biology, Palo Alto, CA) (31).  The 
cDNA probes were hybridized and removed from blots using procedures modified from 
the manufacturer's instructions. 
Results 
CTL Clones Can Proliferate in Response to Alloantigen in the Absence of Exogenous 
IL-2  or Accessory  Cells.  Previous  studies  in  this  laboratory  indicated  that  the 
cytolytic T  cell clone L3, as well as several other CTL clones, was dependent on 
IL-2 for proliferation (4, 32). Although proliferation was enhanced by including 
H-2L  ~ alloantigen,  as well as exogenous IL-2, alloantigen alone did not appear 
to stimulate CTL  L3 cells significantly  under  the conditions  employed in these 
earlier studies. However, we have found that we can induce significant thymidine 
incorporation  in  several different  CTL  clones,  including  CTL  L3  cells,  in  the 
absence of exogenous IL-2, using slightly different assay conditions.  The results 
shown  in  Fig.  1  indicate  that  CTL  L3  cells stimulated  with  alloantigen  in  the 
form of either  T  cell-depleted  allogeneic  DBA/2  splenocytes or  P-815  masto- 
cytoma cells which  bear H-2L  d, or with the clonotypic mAb 384.5,  which binds 
to  the  T  cell  receptor  on  CTL  L3  cells,  incorporate  significant  amounts  of 
tritiated thymidine in a  48-h assay. 
When  CTL  L3 cells were stimulated  with the  indicated numbers of either T 
cell-depleted DBA/2 splencytes or P-815 mastocytoma cells, or with immobilized 
mAb 384.5,  thymidine incorporation  increased in proportion to the responding 
cell number (Fig. 1, A-C). When the concentration of CTL L3 cells was increased, 
greater  numbers  of DBA/2  stimulator  cells  were  required  to  induce  plateau 
levels of stimulation  (Fig.  1A).  At  equivalent  stimulating  cell  numbers,  P-815 1570  INTERLEUKIN  2-1NDEPENDENT  PROLIFERATION  OF  T  CELLS 
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FIGURE  1.  Dose-dependent thymidine incorporation by clone CTL  L3 cells stimulated by 
allogeneic spleen  cells,  P-815  tumor  cells,  or  immobilized mAb  384.5.  CTL  L3  cells (105 
[--]; 3.3  ×  104 [- -];  1.1  ×  104 [---]; or 3.7  x  103 [  .... ]) were cultured with the indicated 
number of either irradiated T  cell-depleted DBA/2 splenocytes (A), mitomycin C-treated P- 
815  mastocytoma cells (B),  or  various dilutions of mAb 384.5  supernatant immobilized in 
microtiter wells 2 h  before the addition of CTL L3 cells (C). The cultures were pulsed with 
[SH]thymidine for the last 12 h  of the 48  h  incubation period. Thymidine incorporation by 
CTL L3 cells in control cultures prepared with C57BL/6 splenocytes was less than 1,500 dpm; 
by CTL L3 cells and irradiated DBA/2 splenocytes and mitomycin-treated P-815 cells alone, 
it was less than 2,000 dpm. MOLDWIN  ET  AL. 
TABLE  II 
Response of CTL Clones to Immobilized  mAbs 
1571 
mAb  Specificity 
[~H]thymidine incorporation 
L3  dB45 
SP2/0  Control  800 +  121  789 +  192 
384.5  Antigen receptor on L3*  259,753 +  10,073  676 +  92 
KJ 16-133  Antigen receptor*  879 +  125  38,847 _+  1,438 
AT83A  Thy-1.2  i ,040 +- 267  838 +  111 
3.155  Lyt-2  951  -+ 40  1,739 +  307 
The indicated mAb-containing culture supernatants were immobilized in microtiter wells for 18 h 
before the addition of 105 CTL clone cells.  Cultures were pulsed with [~H]thymidine for the last 
18 h of the 60 h incubation period. The results are expressed as mean + SEM of triplicate cultures. 
* mAb 384.5 is a clonotypic antibody that detects a determinant present on the antigen receptor of 
CTL clone L3 but is not present on CTL clone dB45. 
* mAb KJ 16-133 recognizes an allotypic determinant that is present on the antigen receptor of CTL 
clone dB45 but is not present on CTL clone L3. 
cells were substantially more stimulatory than DBA/2 splenocytes (Fig.  1 B). The 
optimal  number of P-815 stimulator cells in this experiment was 3.3 X  105 per 
microwell,  regardless  of the  number  of CTL  L3 responder  cells added  to the 
cultures. A sharp peak in the dose response curve for P-815 cells is evident. The 
reduced  response  with  a  greater  number  of  P-815  cells  may  be  due  to  a 
nonspecific inhibitory effect of the P-815 cell membranes (33, 34), or may reflect 
specific  inhibition  by a  high  antigen  dose.  In  the  same  experiment,  T  cell- 
depleted C57BL/6  splenocytes, which  are  syngeneic to CTL  L3  cells, did not 
induce thymidine incorporation  in  CTL  L3 cells (data not shown).  In response 
to the immobilized clonotypic mAb 384.5 (Fig.  1 C), maximal levels of thymidine 
incorporation  were observed with CTL L3 cells when mAb 384.5 supernatants 
at dilutions of up to  1:1000 were used to immobilize the antibody. 
Antibodies  reactive  with  the  TCR  of two T  cell  clones,  CTL  L3 and  CTL 
dB45,  stimulated  only those cells  that  expressed  the appropriate  determinant 
(mAb 384.5 for CTL L3 cells, and mAb KJ16-133 for CTL dB45 cells), as shown 
in  Table  II.  In  repeated  experiments,  mAbs  directed  against  either  Thy-l.2 
(mAb AT83A) or Lyt-2 (mAb 3.155) did not stimulate thymidine incorporation 
by either  of these cloned T  cell populations  (Table  II).  In  other experiments, 
immobilized  mAb directed against  the  IL-2  receptor and  the  LFA-1  complex 
failed to stimulate cloned CTL L3 and CTL dB45 cells (data not shown). 
The kinetics of thymidine incorporation by CTL L3 cells following stimulation 
is shown in  Fig.  2.  CTL  L3 cells were cultured with T  cell-depleted syngeneic 
C57BL/6 or allogeneic DBA/2 spleen cells,  P-815 mastocytoma cells, or AKR- 
A T  lymphoma cells (H-2  k) (Fig. 2A), or with either immobilized mAb 384.5 or 
immobilized mAb KJ16-133 (Fig.  2B). The response of CTL L3 cells to either 
P-815 cells or DBA/2 splenocytes was maximal  at 48 h.  The  response induced 
by DBA/2  splenocytes consistently  remained  elevated through  day  4,  but  the 
response  to  P-815  cells  had  returned  to  background  levels  by  this  time.  In 
repeated experiments,  the peak of thymidine incorporation  always occurred at 
48  h.  The  pattern  of thymidine  incorporation  by CTL  L3  cells produced  by 
stimulation  with  mAb 384.5  differed somewhat from  that  induced  by antigen, 1572  INTERLEUKIN  2-INDEPENDENT  PROLIFERATION  OF  T  CELLS 
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FrCURE 2.  The kinetics of thymidine incorporation by cloned CTL L3 ceils stimulated with 
allogeneic spleen cells, various tumor cells, or immobilized mAb 384.5. (A) CTL L3 cells (5 x 
4  5  10 ) were incubated with either medium (- -  -), 4 x  10  mitomycin C-treated AKR-A tumor 
cells (- - -), 4  X  105 mitomycin C-treated P-815 cells (--), or  106 irradiated T  cell-depleted 
DBA/2  splenocytes  (-  -);  or  (B) with  mAb  384.5  (--)  or  KJ16-133  (-  -)  immobilized in 
microtiter wells 18 h before the addition of 5 x  104 CTL L3 cells.  The cultures were pulsed 
for the last  12 h  of the indicated incubation period.  Thymidine incorporation by CTL  L3 
cells, mitomycin C-treated AKR-A cells and P-815 cells, and irradiated DBA/2 splenocytes 
alone was less than 2,000 dpm. 
remaining detectable up to day 4 (Fig.  2). Furthermore,  as had been seen in the 
dose-response studies, the optimal dose of mAb 384.5 consistently induced more 
thymidine incorporation  than  that  generated  by optimal  numbers  of either  P- 
815 cells or DBA/2 splenocytes. 
Thymidine Incorporation  by CTL L3 Cells Stimulated  by mAb 384.5 Is Associated 
with Entry into Cell Cycle.  To determine  whether the thymidine incorporation 
observed in  CTL  L3  cells stimulated  by immobilized  mAb  384.5  represented 
entry into cell cycle, we analyzed the  DNA content of CTL  L3 cells using the 
fluorescent dye  PI,  which  binds  stoichiometrically  to  DNA  (26).  Fig.  3A  is  a 
histogram  presenting  the  DNA content  of CTL  L3  ceils cultured  for 40  h  in 
culture medium.  Only 2.5%  of these cells are found in  S, G2, and  M phases of 
the  cell  cycle;  essentially  all  of the  unstimulated  CTL  L3  cells are  contained 
within a single peak corresponding to 2n  DNA content of cells in the Gl phase 
of the cell cycle. Fig. 3B is a histogram presenting the DNA content of CTL L3 
cells stimulated  for  40  h  with  10  U/ml  IL-2  (EL-4-SF).  A  significant  number 
(28%) of these cells are contained within  the peaks corresponding to the S, G2, 
and  M  phases  of the  cell  cycle.  Fig.  3C  is  a  histogram  presenting  the  DNA 
content of CTL L3 cells stimulated for 40 h with immobilized mAb 384.5.37% 
of these CTL  L3  cells are  contained  within  the peaks corresponding  to the  S, 
G2, and  M phases of the cell cycle. Thus,  the thymidine incorporation  induced 
by mAb 384.5 reflects entry into the cell cycle. 
In  separate  experiments,  we  determined  cell  numbers  after  stimulation  of 
CTL L3 cells. A two- to sixfold increase in CTL L3 cell numbers was found 4 d 
after stimulation with immobilized mAb 384.5, and a two- to threefold increase 
in cultures prepared with P-815-stimulating cells (data not shown). 
Secretion of Lymphokines by Cloned T Cells After  Stimulation  of the Antigen  Re- 
ceptor.  Immobilized mAb 384.5 and mAb F23.1  were used to stimulate cloned 
T  cells at a cell density (2.5 x  106 cells/ml) that produced high lymphokine titers. 
The production of lymphokine mRNA was also studied under the same experi- 
mental conditions. IL-2 and MAF titers for the supernatants harvested 18 h after MOLDWIN  ET  AL.  1573 
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FIGURE 3.  DNA content of CTL clone CTL L3 cells stimulated  with IL-2 or immobilized 
mAb 384.5.  CTL L3 cells were incubated  for 40 h with either  medium  (A), 10 U/ml  IL-2 
contained  in EL-4 SF (B), or immobilized  mAb 384.5 (C). At the end of the culture period, 
the cells were lysed and the nuclei  were stained with PI.  Fluorescence  was measured using a 
FACS analyzer; 30,000 nuclei were analyzed for each histogram. 
stimulation  with  immobilized  mAb  384.5  or mAb  F23.1  are presented  in Table 
III.  High  levels  of MAF  activity  were  detected  in  18-h  supernatants  from  the 
two cloned  CTL,  L3 and  dB45,  and  from  the  cloned  Th,  L2.  IL-2 activity  was 
high  in the  L2  supernatant,  but undetectable  in the supernatants  from CTL  L3 
or CTL  dB45  cells. 
Supernatants  harvested  at  3  and  6  h  after  stimulation  were  also  assayed  for 
IL-2 activity.  At no time was IL-2 activity detected  in the supernatants  from the 
cloned  CTL.  IL-2  was  readily  detectable  in  supernatants  from  Th  L2  cells  as 
early  as  3  h  after  stimulation  with  immobilized  mAb  F23.1.  The  IL-2  titers  in 
the  L2 supernatants  were highest at  18 h  after stimulation  (data not shown). 
In other experiments,  both  CTL  L3 cells and CTL dB45  cells stimulated  with 
DBA/2  splenocytes,  P-815  mastocytes, or immobilized mAB 384.5 or mAb F23.1 1574  1NTERLEUKIN  2-INDEPENDENT  PROLIFERATION OF  T  CELLS 
TABLE III 
Lymphokine Production by T Cell Clones 
T cell clone  MAF*  IL-2* 
CTL L3  17,900  0 
CTL dB45  14,500  0 
Th L2  25,500  205 
CTL L3 cells (10  X l0 s) were incubated  with the  immobilized mAb 
384.5. CTL dB45 and Th L2 cells (107) were incubated with immobi- 
lized mAb F23.1. The final volume of culture medium was 4 ml. After 
18 h culture supernatants were collected and assayed for MAF and 1L- 
2 activity as described in Materials and Methods. 
* MAF activity is expressed as the titer of culture supernatant that resulted 
in 50% maximal lysis  of 51Cr-labeled target cells as described in Materials 
and Methods. 
* IL-2 activity is expressed as U/ml as described in Materials and Methods. 
consistently secreted MAF within  12 h, but neither CTL clone produced detect- 
able levels of IL-2 (data not shown). 
Proliferation  of CTL Clones Induced by Stimulation of the TCB is Not Inhibited by 
Anti-IL-2-R mAb.  Although proliferation of cloned CTL cells induced by stim- 
ulation of the antigen  receptor was not accompanied by secretion of detectable 
levels of IL-2, it was possible that IL-2 was produced but that the amounts were 
not  high  enough  to  be  detected  in  our  assay.  Therefore,  we  determined  the 
effect of anti-IL-2-R antibodies on proliferation in cloned CTL cells induced by 
IL-2 or by stimulation of the TCR. 
A  mixture  of two anti-IL-2-R antibodies,  mAb PC61.5  plus  mAb  7D4,  was 
used in amounts sufficient to inhibit  maximal levels of thymidine incorporation 
induced  by IL-2.  Proliferation  of Th  L2  cells,  CTL  dB45  cells,  and  CTL  L3 
cells induced by 20  U/ml of IL-2 was profoundly inhibited  by these antibodies, 
as  shown  in  Fig.  4;  B,  D,  and  F,  respectively.  The  anti-IL-2-R  mixture  also 
blocked  the  proliferation  of Th  L2  when  this  clone  was  stimulated  by either 
immobilized mAb F23.1  or  by alloantigen  in  the  form of CBA  spleen  cells,  as 
shown  in  Fig.  4A.  In  contrast,  anti-IL-2-R had no  significant  inhibitory  effect 
on  the  proliferation  of the  CTL  L3  cells  stimulated  with  either  immobilized 
mAb 384.5  or alloantigen  in  the  form of DBA/2  spleen cells,  as shown  in  Fig. 
4E. Also, anti-IL-2-R had no significant inhibitory effect on the proliferation of 
CTL dB45 cells in response to immobilized mAb F23.1, or to alloantigen in the 
form of DBA/2 spleen cells, as shown in Fig. 4C. 
In other experiments with three CTL clones, CTL  L3, dB45, and Bcg, mAb 
PC61.5 alone inhibited the proliferation induced by IL-2. In contrast, we could 
not detect blocking by mAb PC61.5  of the thymidine incorporation  induced by 
P-815 mastocytes (Table IV). None of these three CTL clones secretes detectable 
IL-2 in response to Con A  or alloantigen (data not shown). 
Comparable results  were obtained  when  mAb  3C7  or  7D4  were  used  alone 
with  CTL  L3  and  CTL  dB45  cells stimulated  with  P815  mastocytes (data  not 
shown).  In addition,  a polyclonal rabbit anti-human  IL-2 antiserum (Collabora- 
tive Research,  Inc., Lexington,  MA) was able to block the proliferation of CTL 
L3  cells  induced  by  5  U/ml  of  IL-2,  but  it  had  no  inhibitory  effect  on  the 
proliferation of CTL  L3 cells in response to mAb 384.5 (data not shown). Th 
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FIGURE 4.  Effect ofanti-IL-2-R mAb on Th L2, CTL dB45, and CTL L3 cell proliferation 
induced by IL-2, allogeneic spleen cells, or immobilized mAb 384.5  or mAb F23.1.  Th L2 
cells (5 ×  104) were cultured with either immobilized mAb F23.1, irradiated CBA spleen cells 
(106),  (A),  or with 20  U/ml IL-2 contained in  EL-4-SF (B).  CTL dB45 cells (5  X  104) were 
cultured with either immobilized mAb F23.1, irradiated DBA/2 s~leen cells (106), (C), or with 
20  U/ml IL-2 contained in EL-4-SF,  (D).  CTL  L3 cells (5  X  10 ) were cultured with either 
immobilized mAb  384.5,  irradiated  DBA/2  spleen  cells (106),  (E),  or  with  20  U/ml  IL-2 
contained in EL-4-SF, (F). Hatched bars indicate the addition to the culture wells of a mixture 
containing mAb PC61.5 (final concentration 1:800) and mAb 7D4 (final concentration 1:800). 
Both antibodies were purified from hybridoma supernatants by ammonium sulphate precipi- 
tation. The cultures were pulsed with [3H]thymidine for the last 12 h of the 48 h incubation 
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TARLE IV 
Response of CTL Clones to P-815 Cells Is Not Blocked by Monoclonal Anti-lL-2-R Antibody 
Stimulus 
[SH]thymidine incorporation 
L3  dB45  BC9 
None  654 -+ 114  1,279 +  311  1,196 + 61 
P-815  18,578 +- 2,480  14,908 +  1,914  3,546 +  38 
P-815 +  PC61.5  26,413 +  2,284  12,911  +  455  2,680 +  528 
IL-2  77,913 +  6,433  86,548 +  8,409  37,887 _+ 999 
IL-2 +  PC61.5  1,257  +  318  15,610 +  2,850  1,772 +  269 
Cells of the indicated CTL clone (5 ×  104) were incubated with either medium, 3 x  10 ~ mitomycin 
C-treated  P-815  mastocytoma cells,  or  with  3  U/ml  of IL-2  (EL-4  SF).  mAb  PC61.5  culture 
supernatant at a final dilution of 1:6 was added to the indicated wells. The cultures were pulsed with 
[3Hlthymidine for the  last  12  h  of the  48  h  incubation period.  [3H]thymidine incorporation by 
mitomycin C-treated P-815 mastocytoma cells alone was 155 +  20 dpm. 
Cloned CTL Cells Produce IFN-'y mRNA But Not IL-2 mRNA After Stimulation of 
the TCR.  The data presented above indicated that secreted IL-2 did not mediate 
the  proliferation  of these  CTL  clones  initiated  by  stimulation  of the  TCR. 
However, it was possible that production of IL-2 was induced by TCR stimula- 
tion, but that IL-2 might have reacted with its receptor either intracellularly or 
in the local microenvironment in ways that would make it undetectable in culture 
supernatants and inaccessible to the inhibitory effects of anti-IL-2-R antibody. 
Therefore, we cultured CTL L3 cells with immobilized mAb 384.5, and CTL 
dB45 and Th L2 cells with immobilized mAb F23.1, and measured IFN-7 and 
IL-2 mRNA in the total RNA extracts from the cells after stimulation for several 
periods of time.  IL-2  mRNA  was  detected on dot blots or  Northern blots by 
hybridizing the blots to a 32p-labeled  cDNA probe for IL-2. The probe was then 
removed, and  the blots  were rehybridized with a  cDNA probe  for IFN-7,  as 
described in Materials and Methods. As shown in Fig. 5B, IFN-~ mRNA could 
be detected in CTL L3, CTL dB45, and Th L2 cells within 3 h after stimulation 
with immobilized mAb 384.5 or mAb F23.1.  However, as seen in Fig. 5A, the 
dots containing CTL E3 and CTL dB45 mRNA that showed a strong signal for 
1FN-q, mRNA did not contain detectable IL-2 mRNA. In contrast, IL-2 mRNA 
was detected in Th L2 cells stimulated with mAb F23.1  for 6  h. The IL-2 and 
MAF titers from the  18  h  supernatants of these cloned T  cells are  shown  in 
Table  III.  Collectively, these  findings show that TCR stimulation can  induce 
cloned CTL L3 and CTL dB45 to proliferate and secrete IFN-7, but not IL-2, 
in the absence of exogenous IL-2. 
Discussion 
CTL clones that incorporate thymidine in response to stimulation with alloan- 
tigen in the absence of exogenous IL-2 have been described previously (6-8, 35, 
36).  Widmer and  Bach (6)  designated such  CTL as  "helper-cell independent" 
and suggested that such cells might produce IL-2 (or other lymphokines) which 
caused cell proliferation. In fact, IL-2 production has been documented for some 
but  not all  Th-independent CTL  clones (8,  36);  for other  CTL clones,  IL-2 
production was not measured (7). However, studies using mixed populations of MOLDWIN  ET  AL.  |577 
FIGURE 5.  Production  of lymphokine  mRNA  by  cloned  CTL  and  Th  stimulated  with 
immobilized mAb 384.5 or mAb F23.1. Th L2 cells and CTL dB45 cells were stimulated with 
immobilized mAb F23.1  and CTL L3 cells were stimulated with immobilized mAb 384.5 for 
the  indicated  periods of time,  after  which  the  supernatants and  cells were harvested, as 
described in Materials and Methods. Dot blots were performed using cDNA probes for IL-2 
(A) and IFN-3~ (B) as described in the Materials and Methods section. 1578  INTERLEUKIN  2-1NDEPENDENT  PROLIFERATION  OF  T  CELLS 
stimulating cells  are  inherently difficult to  interpret.  It seemed probable  that 
secretion of small amounts of IL-2 either by Th-independent CTL themselves 
or by Th remaining in the stimulating cell population accounted for the thymi- 
dine incorporation induced by alloantigen. The latter problem was avoided in 
the  present  studies  by  stimulating cloned  CTL  and  Th  with  mAb  directed 
specifically against the TCR. The responses observed were comparable to those 
obtained  when  the  cloned  cells  were  stimulated with  alloantigen.  Using  this 
approach, we have been able to show that at least some conventional CTL cells 
can be stimulated through the TCR to proliferate, as evidenced by incorporation 
of thymidine, entry into  cell  cycle, and  increase  in  cell  number  via  an IL-2- 
independent pathway. 
Several recent refinements in culture conditions account for our current ability 
to detect thymidine incorporation in cloned CTL cells in the absence of exoge- 
nous IL-2. In the present study, the magnitude of thymidine incorporation was 
influenced both by the number of CTL L3 cells and by the number ofallogeneic 
stimulating cells (Fig. 1). The thymidine incorporation detected was found to be 
directly proportional  to  the  concentration of CTL  L3  cells  (e.g.,  a  threefold 
increase  in  CTL  L3  cell  concentration  resulted  in  a  threefold  increase  in 
thymidine incorporation). In previous studies, thymidine incorporation by rela- 
tively small numbers of CTL L3 cells usually was measured after 5 d of culture, 
a  time  that  was  found  to  be  optimal  when  alloantigen and  IL-2  were  used 
together  (4). Since  the  previous  experiments  used  assays  that  were  usually 
harvested after 3-5 d of culture and used fewer cloned T  cells per culture well, 
significant thymidine incorporation was  not readily observed.  In contrast, the 
assays used for this report used at least 5 x  104 cloned T  cells per microwell and 
were harvested after 48 h of culture. 
Several lines of evidence argue against a role for IL-2 in the proliferation of 
CTL stimulated via the TCR. First, although high levels of IFN-'/, as reflected 
by MAF activity, were found in culture supernatants from CTL clones that were 
proliferating in response to stimulation with T  cell-depleted allogeneic spleen 
cells,  allogeneic tumor cells,  or immobilized mAb reactive with the TCR,  IL-2 
was not detected. It could be argued that CTL L3 and CTL dB45 cells,  since 
they have IL-2 receptors, may have absorbed all the IL-2 that they might have 
produced. However, when the numbers of CTL L3 and CTL dB45 cells used in 
these experiments were cultured in  1 U/ml IL-2, small but detectable amounts 
of IL-2 remained at 24 h. Therefore, had the CTL cells produced 1 U/ml of 1L- 
2 over a period of 24 h, it is likely that it would have been detected in our IL-2 
assay. 
Second, in repeated experiments, mAbs reactive with the cell surface receptor 
for IL-2 did not inhibit proliferative responses of these CTL clones in response 
to stimulation of the TCR, whereas these mAbs inhibited IL-2-induced prolif- 
eration of the same CTL clones.  In contrast, the cloned Th  L2 cells  secreted 
large amounts of IL-2 into the medium after stimulation of the TCR. The anti- 
IL-2-R antibodies profoundly inhibited both TCR-driven and IL-2-driven prolif- 
eration of the IL-2-producing Th  L2 clone.  Apparently, Th  L2 cells  that are 
stimulated via  the TCR proliferate predominantly via an IL-2-mediated, auto- 
crine pathway. MOLDWIN ET  AL.  1579 
Third, although we repeatedly detected IFN-3, mRNA in all the T  cell clones 
tested,  we  consistently  were  unable  to  show  the  presence  of IL-2  mRNA  in 
cloned CTL L3 and dB45 cells, whereas it was readily detectable in cloned Th 
L2 cells. These findings appear to exclude the possibility that  unsecreted  IL-2 
could act intracellularly to mediate the activation of the cloned CTL cells. 
Although our data show an IL-2-independent pathway for CTL activation, IL- 
2  appears  also  to  have  an  important  role  in  many  situations.  IL-2  alone  can 
induce sustained proliferation in our CTL clones (37). Furthermore, a profound 
synergistic  effect  is  observed  when  L3  cells  are  stimulated  with  alloantigen 
together  with  IL-2  (38),  and  T  cell-depleted  syngeneic  splenic adherent  cells 
appear  to  enhance  L3  proliferation  induced  by  P-815  mastocytes  (data  not 
shown).  Thus,  IL-2  and  accessory  cells  may  influence  the  magnitude  of the 
response initiated by and dependent upon stimulation of the TCR. 
The  importance  of the  IL-2-independent  pathway for immune  responses  in 
vivo  remains  to  be  determined.  This  pathway  could  be  important  for  CTL 
proliferation  in  microenvironments  where  T  cell  help  may not  be present.  It 
may be important in the first few days after antigenic challenge, or it may operate 
intermittently  only after  a  repeated  challenge.  It  may operate  in  immune  re- 
sponses where only differences in class  I  MHC antigens  are present.  In  fact, it 
has  recently  been  reported  that  T  lymphocytes bearing  surface  Lyt-2 but not 
L3T4 can respond to class I MHC antigen in the absence of L3T4 + lymphocytes 
(39). However, the role of IL-2 in such responses was not evaluated. 
In addition to these questions, it remains unclear whether the TCR-driven IL- 
2-independent pathway shown here for CTL also operates in Th. This route of 
T  cell activation  in CTL may also involve different biochemical pathways than 
the  IL-2-dependent pathway used by Th.  CTL clones that can be activated via 
the TCR through an IL-2-independent pathway for proliferation and lymphokine 
production provide a model system for investigating these questions. 
Summary 
Proliferation  of T  lymphocytes can  be  induced  by  IL-2,  either  through  an 
autocrine pathway in which the responding cell produces its own IL-2 or through 
an exocrine pathway in which IL-2 secreted by Th stimulates proliferation of IL- 
2-dependent CTL.  However, proliferation of at least some CTL clones, such as 
CTL  L3  and  CTL  dB45,  also can  be  induced  by stimulation  of the  antigen 
receptor in  the absence of IL-2.  Stimulation  of these cloned CTL  with  T  cell- 
depleted  allogeneic  spleen  cells,  allogeneic  tumor  cells,  or  immobilized  mAb 
reactive with the T cell antigen receptor (TCR) induced thymidine incorporation, 
entry into  cell cycle, and  secretion of macrophage  activating  factor,  but these 
stimuli did not induce the secretion of IL-2. Several observations indicated that 
such  proliferation  of cloned  CTL  induced  by  stimulation  of the  TCR  was 
independent of I L-2; IL-2 could not be detected in supernatants from stimulated 
CTL  cells,  mAbs  reactive  with  the  murine  IL-2-R  efficiently  blocked  IL-2- 
mediated thymidine incorporation in cloned CTL and Th, but had no inhibitory 
effect on TCR-driven  thymidine incorporation  in the CTL clones. TCR-driven 
thymidine incorporation in cloned Th L2 cells was profoundly inhibited by these 
antibodies, indicating the operation of an IL-2-mediated autocrine pathway for 1580  INTERLEUK1N  2-1NDEPENDENT  PROLIFERATION  OF  T  CELLS 
proliferation  in  this  cloned  Th.  When  antibodies  to  the  TCR  were  used  to 
stimulate  cloned  CTL  and  Th,  IFN-3,  mRNA  was  easily shown  in  the  cloned 
CTL and Th. Although  IL-2 mRNA could be detected in the cloned Th, it was 
never  observed  in  the  cloned  CTL.  These  findings  provide  evidence  for  the 
existence of a TCR-mediated, I L-2-independent pathway for induction of cellular 
proliferation in cloned murine CTL. 
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